501 filings
Page 10 of 26
SC 13G
AADI
Aadi Bioscience Inc
23 Aug 21
Aerpio Pharmaceuticals / RA CAPITAL MANAGEMENT ownership change
4:30pm
8-K
AADI
Aadi Bioscience Inc
18 Aug 21
Submission of Matters to a Vote of Security Holders
12:00am
10-Q
2021 Q2
AADI
Aadi Bioscience Inc
Quarterly report
11 Aug 21
4:44pm
8-K
AADI
Aadi Bioscience Inc
11 Aug 21
Aerpio Reports Second Quarter 2021 Financial Results
4:20pm
8-K
AADI
Aadi Bioscience Inc
26 Jul 21
Aadi Bioscience Announces FDA Acceptance and Priority Review for the New Drug Application of FYARROâ„¢ for the Treatment of Advanced Malignant PEComa
8:01am
SC 13G
AADI
Aadi Bioscience Inc
12 Jul 21
Aerpio Pharmaceuticals / RA CAPITAL MANAGEMENT ownership change
4:30pm
DEFM14A
AADI
Aadi Bioscience Inc
8 Jul 21
Proxy related to merger
9:24am
4
Dalal Anupam
2 Jul 21
Aerpio Pharmaceuticals / Anupam Dalal ownership change
5:38pm
4
AADI
Aadi Bioscience Inc
2 Jul 21
Aerpio Pharmaceuticals / Steven Prelack ownership change
5:38pm
4
Dugel Pravin
2 Jul 21
Aerpio Pharmaceuticals / Pravin Dugel ownership change
5:38pm
4
AADI
Aadi Bioscience Inc
2 Jul 21
Aerpio Pharmaceuticals / Caley Castelein ownership change
5:37pm
4
Cohen Cheryl
2 Jul 21
Aerpio Pharmaceuticals / Cheryl Cohen ownership change
5:34pm
4
Cohen Cheryl
22 Jun 21
Aerpio Pharmaceuticals / Cheryl Cohen ownership change
5:42pm
PREM14A
AADI
Aadi Bioscience Inc
21 Jun 21
Preliminary proxy related to merger
7:31am
DEFA14A
AADI
Aadi Bioscience Inc
9 Jun 21
Additional proxy soliciting materials
9:00am
DEF 14A
AADI
Aadi Bioscience Inc
Definitive proxy
9 Jun 21
8:51am
DEFA14A
AADI
Aadi Bioscience Inc
4 Jun 21
Additional proxy soliciting materials
9:36am
8-K
AADI
Aadi Bioscience Inc
4 Jun 21
Aerpio Provides Second Update on Aadi Bioscience Presentation at the ASCO 2021 Virtual Meeting
9:35am
SC 13D
Avoro Capital Advisors LLC
4 Jun 21
Aerpio Pharmaceuticals / Avoro Capital Advisors ownership change
8:30am
SC 13G
Point72 Asset Management, L.P.
26 May 21
Aerpio Pharmaceuticals / Point72 Asset Management ownership change
5:01pm